Maternal-Fetal Medicine Department, General Hospital of Mexico, 'Dr Eduardo Liceaga', Mexico City, Mexico.
Clinical Research Branch, National Institute of Perinatology, Mexico City, Mexico.
Ultrasound Obstet Gynecol. 2022 Jan;59(1):76-82. doi: 10.1002/uog.24797. Epub 2021 Dec 17.
Mortality in pregnancy due to coronavirus disease 2019 (COVID-19) is a current health priority in developing countries. Identification of clinical and sociodemographic risk factors related to mortality in pregnant women with COVID-19 could guide public policy and encourage such women to accept vaccination. We aimed to evaluate the association of comorbidities and socioeconomic determinants with COVID-19-related mortality and severe disease in pregnant women in Mexico.
This is an ongoing nationwide prospective cohort study that includes all pregnant women with a positive reverse-transcription quantitative polymerase chain reaction result for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from the Mexican National Registry of Coronavirus. The primary outcome was maternal death due to COVID-19. The association of comorbidities and socioeconomic characteristics with maternal death was explored using a log-binomial regression model adjusted for possible confounders.
There were 176 (1.35%) maternal deaths due to COVID-19 among 13 062 consecutive SARS-CoV-2-positive pregnant women. Maternal age, as a continuous (adjusted relative risk (aRR), 1.08 (95% CI, 1.05-1.10)) or categorical variable, was associated with maternal death due to COVID-19; women aged 35-39 years (aRR, 3.16 (95% CI, 2.34-4.26)) or 40 years or older (aRR, 4.07 (95% CI, 2.65-6.25)) had a higher risk for mortality, as compared with those aged < 35 years. Other clinical risk factors associated with maternal mortality were pre-existing diabetes (aRR, 2.66 (95% CI, 1.65-4.27)), chronic hypertension (aRR, 1.75 (95% CI, 1.02-3.00)) and obesity (aRR, 2.15 (95% CI, 1.46-3.17)). Very high social vulnerability (aRR, 1.88 (95% CI, 1.26-2.80)) and high social vulnerability (aRR, 1.49 (95% CI, 1.04-2.13)) were associated with an increased risk of maternal mortality, while very low social vulnerability was associated with a reduced risk (aRR, 0.47 (95% CI, 0.30-0.73)). Being poor or extremely poor were also risk factors for maternal mortality (aRR, 1.53 (95% CI, 1.09-2.15) and aRR, 1.83 (95% CI, 1.32-2.53), respectively).
This study, which comprises the largest prospective consecutive cohort of pregnant women with COVID-19 to date, has confirmed that advanced maternal age, pre-existing diabetes, chronic hypertension, obesity, high social vulnerability and low socioeconomic status are risk factors for COVID-19-related maternal mortality. © 2021 International Society of Ultrasound in Obstetrics and Gynecology.
在发展中国家,2019 年冠状病毒病(COVID-19)导致的孕妇死亡率是当前的一个主要健康问题。确定与 COVID-19 相关的孕妇死亡率相关的临床和社会人口学危险因素,可以为公共政策提供指导,并鼓励这些妇女接受疫苗接种。我们旨在评估墨西哥 COVID-19 孕妇的合并症和社会经济决定因素与 COVID-19 相关死亡率和严重疾病的相关性。
这是一项正在进行的全国性前瞻性队列研究,包括墨西哥严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)国家登记处中所有 SARS-CoV-2 阳性孕妇的病例。主要结局是 COVID-19 导致的孕产妇死亡。使用对数二项式回归模型,调整了可能的混杂因素,探讨了合并症和社会经济特征与孕产妇死亡的关系。
在 13062 例连续的 SARS-CoV-2 阳性孕妇中,有 176 例(1.35%)死于 COVID-19。孕产妇年龄,无论是连续变量(调整后的相对风险(aRR),1.08(95%CI,1.05-1.10))还是分类变量,均与 COVID-19 相关的孕产妇死亡相关;与年龄<35 岁的妇女相比,年龄在 35-39 岁(aRR,3.16(95%CI,2.34-4.26))或 40 岁及以上(aRR,4.07(95%CI,2.65-6.25))的妇女死亡风险更高。与孕产妇死亡率相关的其他临床危险因素包括既往糖尿病(aRR,2.66(95%CI,1.65-4.27))、慢性高血压(aRR,1.75(95%CI,1.02-3.00))和肥胖(aRR,2.15(95%CI,1.46-3.17))。极高的社会脆弱性(aRR,1.88(95%CI,1.26-2.80))和高社会脆弱性(aRR,1.49(95%CI,1.04-2.13))与孕产妇死亡率风险增加相关,而极低的社会脆弱性与降低的风险相关(aRR,0.47(95%CI,0.30-0.73))。贫穷或极度贫穷也是孕产妇死亡的危险因素(aRR,1.53(95%CI,1.09-2.15)和 aRR,1.83(95%CI,1.32-2.53))。
本研究包括迄今为止最大的前瞻性连续 COVID-19 孕妇队列,证实了高龄产妇、既往糖尿病、慢性高血压、肥胖、高社会脆弱性和低社会经济地位是与 COVID-19 相关孕产妇死亡率的危险因素。©2021 年国际妇产科超声学会。